Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Car, B. D.
Right arrow Articles by Anderson, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Car, B. D.
Right arrow Articles by Anderson, T. D.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

The Toxicology of Interleukin-12: A Review

Bruce D. Car

Safety Assessment, DuPont Pharmaceuticals Company, Newark, Delaware 19714-0030, DuPont Pharmaceuticals, Stine-Haskell Research Center, Building 320, Newark, Delaware 19714-0030, bruce.d.car.2{at}dupontpharma.com.

Vicki M. Eng

Unit of Laboratory Animal Resources, University of Pennsylvania, Philadelphia, Pennsylvania 19104

Jack M. Lipman

Department of Toxicology and Pathology, Hoffinan-La Roche, Nutley, New Jersey 07110

Timothy D. Anderson

Department of Toxicology and Pathology, Hoffinan-La Roche, Nutley, New Jersey 07110

Recombinant murine interleukin (IL)-12 (rmIL-12) exhibits antitumor, antiviral, and antimicrobial activities and can modify allergic inflammatory reactions in animal models. Recombinant human IL-12 (rhIL-12) is currently in clinical trials for treatment of cancer, asthma, and viral hepatitis. Principally a phagocyte-derived cytokine, IL-12 targets natural killer cells and T lymphocytes, stimulating their activity and the secretion of interferon (IFN)-{gamma}. An understanding of the toxicology of IL-12, due in part to effects mediated by IFN-{gamma}, has emerged from preclinical safety and mechanistic studies and initial clinical trials. Target organs common to several animal species and humans include the lymphohematopoietic system, intestines, liver, and lung.

Key Words: Interferon-{gamma} • mouse • guinea pig • squirrel monkey • cynomolgus macaque • chimpanzee • human • hematopoeisis • liver • intestine • lung • IL- 12

References

  • Aggarwal BB, Eessalu TE, and Hass PE (1985). Characterization of receptors for human tumor necrosis factor and their regulation by gamma-interferon. Nature 318: 665-667.[CrossRef][Medline] [Order article via Infotrieve]
  • Anderson TD, Powers GD, Gately MK, Tudor R., Rushton A., and Hayes TJ (1993). Comparative toxicity and pathology associated with administration of recombinant IL-2 to animals. Int. Rev. Exp. Pathol. 34A: 58-72.
  • Bajetta E., Del Vecchio M, Mortarini R., Nadeau R., Rakhit A., Rimassa L., Fowst C., Borri A., Anichini A., and Parmiani G. (1998). Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma. Clin. Cancer Res. 4: 75-85.[Abstract]
  • Barbulescu K., Becker C., Schlaak JF, Schmitt E., Meyer zum Buschenfelde KH, and Neurath MF (1998). IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4- T lymphocytes. J. lmmunol. 160: 3642—3647.[Abstract/Free Full Text]
  • Bellone G. and Trinchieri G. (1994). Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis. J. Immunol. 153: 930-937.[Abstract]
  • Bree AG, Schlerman FJ, Kaviani MD, Hastings RC, Hitz SL, and Goldman SJ (1994). Multiple effects on peripheral hematology following administration of recombinant human interleukin 12 to nonhuman primates. Biochem. Biophys. Res. Commun. 204: 1150-1157.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Brunda MJ, Luistro L., Rumennik L., Wright RB, Dvorozniak M., Aglione A., Wigginton JM, Wiltrout RH, Hendrzak JA, and Palleroni AV (1996). Antitumor activity of interleukin 12 in preclinical models. Cancer Chemother. Pharmacol. 38(suppl.): S16—S21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Car BD, Eng VM, Schnyder B., Shakhov A., Woerly G., Steckholzer U., Huang S., Aguet M., Anderson TD, and Ryffel B. (1995). IL-12 induced in vivo pathologic alterations are modified in interferon-{gamma} receptor negative mice. Am. J. Pathol. 147: 1693-1707.[Abstract]
  • Chan SH, Perussia B., Gupta JW, Kobayashi M., Posposil M., Young HA, Wolf StF, Young D., Clark SC, and Trinchieri G. (1991). Induction of interferon-{gamma} production by natural killer cell stimulation factor: Characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173: 869-869.[Abstract/Free Full Text]
  • Chen L., Chen D., Block E., O'Donnell M., Kufe DW, and Clinton SK (1997). Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer. J. Immunol. 159: 351-359.[Abstract]
  • Cohen J. (1995). IL-12 deaths: Explanation and a puzzle. Science 270: 5238.
  • Coughlin CM, Wysocka M., Trinchieri G., and Lee WM (1997). The effect of interleukin 12 desensitization on the antitumor efficacy of recombinant interleukin 12. Cancer Res. 57: 2460-2467.[Abstract/Free Full Text]
  • D'Andrea A., Rengaraju M., Valiante NM, Chehimi J., Kubin M., Aste M., Chan SH, Kobayashi M., Young D., Nickbarg E., Chizzonite R., Wolf SF, and Trinchieri G. (1992). Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176: 1387-1398.[Abstract/Free Full Text]
  • Dranoff G., Crawford AD, Sadelain M., Ream B., Rashid A., Bronson RT, Dickerin GR, Bachurski CJ, Mark EL, Whitsett JA, and Mulligan RC (1994). Involvement of granulocyte-macrophage colony stimulating factor in pulmonary homeostasis. Science 264: 713-716.[Abstract/Free Full Text]
  • Emery I., Leclerc C., Sengphommachanh K., Vuitton DA, and Liance M. (1998). In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis. Parasit. Immunol. 20: 81-91.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Eng VM, Car BD, Schnyder B., Lorenz M., Lugli S., Aguet M., Anderson TD, Ryffel B., and Quesniaux Vfj (1995). The stimulatory effects of interleukin-12 on hematopoiesis are inhibited by IL-12 induced IFN-{gamma} in vivo. J. Exp. Med. 181: 1893-1898.[Abstract/Free Full Text]
  • Gately MK, Warrier RR, Honasoge S., Carvajal DM, Faherty DA, Connaughton SE, Anderson TD, Sarmiento U., Hubbard BR, and Murphy M. (1994). Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-{gamma} in vivo. Int. Immunol. 6: 157-167.[Abstract/Free Full Text]
  • Golab J., Stoklosa T., Zagozdzon R., Kaca A., Giermasz A., Pojda Z., Machaj E., Dabrowska A., Feleszko W., Lasek W., Iwan-Osiecka A., and Jakóbisiak M. (1998). G-CSF prevents the suppression of bone marrow hematopoiesis induced by IL-12 and augments its antitumor activity in a melanoma model in mice. Ann. Oncol. 9: 63-69.[Abstract/Free Full Text]
  • Golab J., Zagozdzon R., Stoklosa T., Lasek W., Jakóbisiak M., Pojda Z., and Machaj E. (1998). Erythropoietin prevents the development of interleukin-12-induced anemia and thrombocytopenia but does not decrease its antitumor activity in mice. Blood 91: 4387-4388.[Free Full Text]
  • Greenberger MJ, Kunkel SL, Strieter RM, Lukacs NW, Bramson J., Gauldie J., Graham FL, Hitt M., Danforth JM, and Standiford TJ (1996). IL-12 gene therapy protects mice in lethal Klebsiella pneumonia infection. J. Immunol. 157: 3006-3012.[Abstract]
  • Guardiola J. and Maffei A. (1993). Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases. Crit. Rev. Immunol. 13: 247-268.[Web of Science][Medline] [Order article via Infotrieve]
  • Hall LB, Lipman JM, and Anderson TD (1993). Skeletal muscle changes in mice treated with recombinant murine interleukin 12. Toxicol. Pathol. 21: 593.
  • Hall LB, Slater C., Catala AR, and Lipman JM (1998). The toxicologic profile of Ro 24-7472 (recombinant human interleukin-12) in guinea pigs and cynomolgus monkeys following two weeks of subcutaneous administration. Toxicol. Pathol. 26: 835 (abstract).
  • Hall SS (1995). IL-12 at the crossroads. Science 268: 1432-1435.[Free Full Text]
  • Hayes-Donelly L., Erickson J., Mason L., Clark E., and Bouchard P. (1998). Characterization of IL-12-induced pulmonary lesions in IFN{gamma} receptor knock out mice. FASEB J. 12: A789.
  • Hilkins C., Snijders A., Vermeulen H., van der Meide P., Wierenga E., and Kapsenberg M. (1996). Accessory cell-derived interleukin-12 and prostaglandin E2 determine the level of interferon-{gamma} produced by activated human CD4 T cells. Ann. N. Y. Acad. Sci. 795: 349-353.[Medline] [Order article via Infotrieve]
  • Huang S., Hendriks W., Althage A., Hemmi S., Blüthmann H., Kamijo R., Vilcek R., Zinkernagel RM, and Aguet M. (1993). Immune response in mice that lack the interferon-{gamma} receptor. Science 259: 1742-1745.[Abstract/Free Full Text]
  • Jacobsen SE, Okkenhaug C., Myklebust J., Veiby OP, and Lyman SD (1995). The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells: In vitro synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J. Exp. Med. 181: 1357-1363.[Abstract/Free Full Text]
  • Kennedy BP, Payette P., Mudgett J., Vadas P., Pruzanski W., Kwan M., Tang C., Rancourt DE, and Cromlish WA (1995). A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J. Biol. Chem. 270: 22378-22385.[Abstract/Free Full Text]
  • Kobayashi K., Kasama T., Yamazaki J., Hosaka M., Katsura T., Mochizuki T., Soejima K., and Nakamura RM (1995). Protection of mice from Mycobacterium avium infection by recombinant interleukin-12. Antimicrob. Agents Chemother. 39: 1369—1371.[Abstract]
  • Kobayashi M., Fitz L., Ryan M., Hewick RM, Clark SC, Chan S., Loudon R., Sherman F., Perussia B., and Trinchieri G. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170: 827-845.[Abstract/Free Full Text]
  • Kurzrock R., Rosenblum MG, Sherwin SA, Rios A., Talpaz M., Quesada JR, and Gutterman JU (1985). Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients. Cancer Res. 45: 2866-2872.[Abstract/Free Full Text]
  • Leonard JP, Sherman ML, Fisher GL, Buchanan LJ, Larsen G., At-kins MB, Sosman JA, Dutcher JP, Vogelzang NJ, and Ryan JL (1997). Effects of single-dose interleukin-12 exposure on interleukin- 12—associated toxicity and interferon-gamma production. Blood 90: 2541-2548.[Abstract/Free Full Text]
  • Liu W. and Kurlander RJ (1995). Analysis of the interrelationship between IL-12, TNF-alpha, and IFN-gamma production during murine listeriosis. Cell. Immunol. 163: 260-267.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lotze MT, Trinchieri G, Gately M, and Wolf S (eds) (1996). Interleukin 12: Cellular and molecular immunology of an important regulatory cytokine. Ann. N. Y. Acad. Sci. 795: 1-454.[Medline] [Order article via Infotrieve]
  • Ma X., Chow JM, Gri G., Carra G., Gerosa F., Wolf SF, Dzialo R., and Trinchieri G. (1996). The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183: 147-157.[Abstract/Free Full Text]
  • Malfait AM, Butler DM, Presky DH, Maini RN, Brennan FM, and Feldmann M. (1998). Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis. Clin. Exp. Immunol. 111: 377-383.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Morris SC, Madden KB, Adamovicz JJ, Gause WC, Hubbard BR, Gately MK, and Finkelman FD (1994). Effects of IL-12 on in vivo cytokine gene expression and Ig isotope selection. J. Immunol. 152: 1047-1056.[Abstract]
  • Orange JS, Salazar-Mather TP, Opal SM, Spencer RL, Miller AH, McEwen BS, and Biron CA (1995). Mechanism of interleukin 12-mediated toxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181: 901-914.[Abstract/Free Full Text]
  • Ozmen L., Aguet M., Trinchieri G., and Garotta G. (1995). The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon. J. Virol. 69: 8147-8150.[Abstract]
  • Paul WE and Seder RA (1994). Lymphocyte responses and cytokines. Cell 76: 241-251.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ploemacher RE, van Soest PL, Boudewijn A., and Neben S. (1993). Interleukin-12 enhances interleukin-3 dependent multilineage hematopoietic colony formation stimulated by interleukin-11 or Steel factor. Leukemia 7: 1374-1380.[Web of Science][Medline] [Order article via Infotrieve]
  • Romani L., Puccetti P., and Bistoni F. (1997). Interleukin-12 in infectious diseases. Clin. Microbiol. Rev. 10: 611-636.[Abstract]
  • Ruggiero V., Tavernier J., Fiers W., and Baglioni C. (1986). Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. J. Immunol. 136: 2445-2450.[Abstract]
  • Sarmiento UM, Riley JH, Knaack PA, Lipman JM, Becker JM, Gately MK, Chizzonite R., and Anderson TD (1994). Biologic effects of recombinant human interleukin-12 in squirrel monkeys (Sciureus saimiri). Lab. Invest. 71: 862-873.[Web of Science][Medline] [Order article via Infotrieve]
  • Smith T., Hewson AK, Kingsley CI, Leonard JP, and Cuzner ML (1997). Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat. Am. J. Pathol. 150: 1909-1917.
  • Stanley E., Lieschke GJ, Grail D., Metcalf D., Hodgson G., Gall Jam, Maher DW, Cebon J., Sinickas V., and Dunn AR (1994). Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91: 5592-5596.[Abstract/Free Full Text]
  • Stern AS, Podlaski FJ, Hulmes JD, Pan YC, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T., Chizzonite R., and Gately MK (1990). Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87: 6808-6802.[Abstract/Free Full Text]
  • Sur S., Lam J., Bouchard P., Sigounas A., Holbert D., and Metzger WJ (1996). Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J. Immunol. 157: 4173-4180.[Abstract]
  • Tare NS, Bowen S., Warrier RR, Carvajal DM, Benjamin WR, Riley JH, Anderson TD, and Gately MK (1995). Administration of recombinant interleukin-12 to mice suppresses hematopoiesis in the bone marrow but enhances hematopoiesis in the spleen. J. Interferon Cytokine Res. 15: 377-383.[Web of Science][Medline] [Order article via Infotrieve]
  • Terrell TG and Green JD (1993). Comparative pathology of recombinant murine interferon-{gamma} in mice and recombinant human interferon-{gamma} in cynomolgus monkeys. Int. Rev. Exp. Pathol. 34B: 73-101.
  • Trembleau S., Germann T., Gately MK, and Adorini L. (1995). The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 17: 214-217.[CrossRef][Web of Science]
  • Trembleau S., Penna G., Bosi E., Mortara A., Gately MK, and Adorini L. (1995). Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181: 817-821.[Abstract/Free Full Text]
  • Trinchieri G. (1993). Interleukin-12 and its role in the generation of TH1 cells. Immunol. Today 14: 335-358.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Trinchieri G. (1995). Interleukin-12 and interferon-gamma. Do they always go together? Am. J. Pathol. 147: 1534-1538.[Web of Science][Medline] [Order article via Infotrieve]
  • Trinchieri G., Rengaraju M., D'Andrea A., Valiante NM, Kubin M., Aste M., and Chehimi J. (1993). Producer cells of interleukin-12. Immunol. Today 14: 237-238.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tsung K., Meko JB, Tsung YL, Peplinski GR, and Norton JA (1988). Immune response against large tumors eradicated by treatment with cyclophosphamide and IL-12. J. Immunol. 160: 1369-1377.
  • Williamson E., Garside P., Bradly JA, and Mowat AM (1996). IL-12 is a central mediator of acute graft-versus-host disease in mice. J. Immunol. 157: 689-699.[Abstract]
  • Wolf SF, Temple PA, Kobayashi M., Young D., Dicig M., Lowe L., Dzialo R., Fitz L., Ferenz C., Hewick RM, Kelleher K., Herrman SH, Clark SC, Azzoni L., Chan SH, Trinchieri G., and Perussia B. (1991). Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146: 3074-3081.[Abstract]
  • Zhan Y. and Cheers C. (1995). Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect. Immun. 63: 1387-1390.[Abstract]
  • Zhang T., Kawakami K., Qureshi MH, Okamura H., Kurimoto M., and Saito A. (1997). Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect. lmmun. 65: 3594-3599.[Abstract]
  • Zisman DA, Kunkel SL, Strieter RM, Gauldie J., Tsai WC, Bramson J., Wilkowski JM, Bucknell KA, and Standiford TJ (1997). Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs clearance in murine Escherichia coli peritoneal sepsis. Shock 8: 349-356.[Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 27, No. 1, 58-63 (1999)
DOI: 10.1177/019262339902700112
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
M.-Y. Ho, S.-J. J. Leu, G.-H. Sun, M.-H. Tao, S.-J. Tang, and K.-H. Sun
IL-27 Directly Restrains Lung Tumorigenicity by Suppressing Cyclooxygenase-2-Mediated Activities
J. Immunol., November 15, 2009; 183(10): 6217 - 6226.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Eliopoulos, M. Francois, M.-N. Boivin, D. Martineau, and J. Galipeau
Neo-Organoid of Marrow Mesenchymal Stromal Cells Secreting Interleukin-12 for Breast Cancer Therapy
Cancer Res., June 15, 2008; 68(12): 4810 - 4818.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Yoshimoto, N. Morishima, I. Mizoguchi, M. Shimizu, H. Nagai, S. Oniki, M. Oka, C. Nishigori, and J. Mizuguchi
Antiproliferative Activity of IL-27 on Melanoma
J. Immunol., May 15, 2008; 180(10): 6527 - 6535.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Barbey, P. Baumgaertner, E. Devevre, V. Rubio-Godoy, L. Derre, G. Bricard, P. Guillaume, I. F. Luescher, D. Lienard, J.-C. Cerottini, et al.
IL-12 Controls Cytotoxicity of a Novel Subset of Self-Antigen-Specific Human CD28+ Cytolytic T Cells
J. Immunol., March 15, 2007; 178(6): 3566 - 3574.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
F. Siddiqui, C.-Y. Li, S. M. LaRue, J. M. Poulson, P. R. Avery, A. F. Pruitt, X. Zhang, R. L. Ullrich, D. E. Thrall, M. W. Dewhirst, et al.
A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas
Mol. Cancer Ther., January 1, 2007; 6(1): 380 - 389.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. Franke, W. Lante, E. Kurig, L. G. Zoller, C. Weinhold, and A. Markewitz
Is interferon gamma suppression after cardiac surgery caused by a decreased interleukin-12 synthesis?
Ann. Thorac. Surg., July 1, 2006; 82(1): 103 - 109.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Shimizu, M. Shimamura, T. Owaki, M. Asakawa, K. Fujita, M. Kudo, Y. Iwakura, Y. Takeda, A. D. Luster, J. Mizuguchi, et al.
Antiangiogenic and Antitumor Activities of IL-27.
J. Immunol., June 15, 2006; 176(12): 7317 - 7324.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Hisada, S. Kamiya, K. Fujita, M. L. Belladonna, T. Aoki, Y. Koyanagi, J. Mizuguchi, and T. Yoshimoto
Potent Antitumor Activity of Interleukin-27
Cancer Res., February 1, 2004; 64(3): 1152 - 1156.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Satoh, T. Saika, S. Ebara, N. Kusaka, T. L. Timme, G. Yang, J. Wang, V. Mouraviev, G. Cao, E. M. A. Fattah, et al.
Macrophages Transduced with an Adenoviral Vector Expressing Interleukin 12 Suppress Tumor Growth and Metastasis in a Preclinical Metastatic Prostate Cancer Model
Cancer Res., November 15, 2003; 63(22): 7853 - 7860.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
D. J. Herzyk, P. J. Bugelski, T. K. Hart, and P. J. Wier
Preclinical Safety of Recombinant Human Interleukin-18
Toxicol Pathol, August 1, 2003; 31(5): 554 - 561.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
J. E. A. Portielje, C. H. J. Lamers, W. H. J. Kruit, A. Sparreboom, R. L. H. Bolhuis, G. Stoter, C. Huber, and J. W. Gratama
Repeated Administrations of Interleukin (IL)-12 Are Associated with Persistently Elevated Plasma Levels of IL-10 and Declining IFN-{gamma}, Tumor Necrosis Factor-{alpha}, IL-6, and IL-8 Responses
Clin. Cancer Res., January 1, 2003; 9(1): 76 - 83.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
F. Shi, A. L. Rakhmilevich, C. P. Heise, K. Oshikawa, P. M. Sondel, N.-S. Yang, and D. M. Mahvi
Intratumoral Injection of Interleukin-12 Plasmid DNA, Either Naked or in Complex with Cationic Lipid, Results in Similar Tumor Regression in a Murine Model
Mol. Cancer Ther., September 1, 2002; 1(11): 949 - 957.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Lohr, Q. Huang, K. Hu, M. W. Dewhirst, and C.-Y. Li
Systemic Vector Leakage and Transgene Expression by Intratumorally Injected Recombinant Adenovirus Vectors
Clin. Cancer Res., November 1, 2001; 7(11): 3625 - 3628.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. E. Ullrich and H. J. Lyons
Mechanisms Involved in the Immunotoxicity Induced by Dermal Application of JP-8 Jet Fuel
Toxicol. Sci., December 1, 2000; 58(2): 290 - 298.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
J. D. Rempel, M. Wang, and K. T. HayGlass
Failure of rIL-12 administration to inhibit established IgE responses in vivo is associated with enhanced IL-4 synthesis by non-B/non-T cells
Int. Immunol., July 1, 2000; 12(7): 1025 - 1034.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. Narvaiza, G. Mazzolini, M. Barajas, M. Duarte, M. Zaratiegui, C. Qian, I. Melero, and J. Prieto
Intratumoral Coinjection of Two Adenoviruses, One Encoding the Chemokine IFN-{gamma}-Inducible Protein-10 and Another Encoding IL-12, Results in Marked Antitumoral Synergy
J. Immunol., March 15, 2000; 164(6): 3112 - 3122.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Car, B. D.
Right arrow Articles by Anderson, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Car, B. D.
Right arrow Articles by Anderson, T. D.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?